Skip to content

Cannabis: all studies

Page 92 of 289: studies 911 to 920 of 2,882, newest first. Back to the cannabis overview

Research

Cannabidiol (CBD) content in vaporized cannabis does not prevent tetrahydrocannabinol (THC)-induced impairment of driving and cognition

Psychopharmacology May 1, 2019 Thomas R. Arkell, Nicholas Lintzeris, Richard C. Kevin et al. 177 citations

BACKGROUND: The main psychoactive component of cannabis, delta-9-tetrahydrocannabinol (THC), can impair driving performance. Cannabidiol (CBD), a non-intoxicating cannabis component, is thought to mitigate certain adverse effects of THC. It is possible then that cannabis containing equivalent CBD and THC will differentially affect driving and cognition relative to THC-dominant cannabis. AIMS:...

Functional effects of synthetic cannabinoids versus Δ9 -THC in mice on body temperature, nociceptive threshold, anxiety, cognition, locomotor/exploratory parameters and depression.

Addiction Biology May 1, 2019 Shaul Schreiber, Miaad Bader, Tatiana Lenchinski et al. 30 citations

Synthetic cannabinoids are psychoactive substances designed to mimic the euphorigenic effects of the natural cannabis. Novel unregulated compounds appear once older compounds become illegal. It has been previously reported that synthetic cannabinoids are different than Δ9 -tetrahydrocannabinol (Δ9 -THC) as they have chemical structures unrelated to Δ9 -THC, different metabolism and, often,...

DOI: 10.1111/adb.12606 (opens in new tab) Full text (opens in new tab) Ab-chminaca Ab-fubinaca Pb-22 Cognition +2

Dissociable effects of cannabis with and without cannabidiol on the human brain’s resting-state functional connectivity

Journal of Psychopharmacology April 23, 2019 Matthew B. Wall, Rebecca Pope, Tom P. Freeman et al. 89 citations

BACKGROUND: -tetrahydrocannabinol (THC) and cannabidiol (CBD). THC is the main psychoactive component; CBD may buffer the user against the harmful effects of THC. AIMS: We examined the effects of two strains of cannabis and placebo on the human brain's resting-state networks using fMRI. METHODS: Seventeen healthy volunteers (experienced with cannabis, but not regular users) underwent three drug...

Psychopathological symptoms associated with synthetic cannabinoid use: a comparison with natural cannabis.

Psychopharmacology April 9, 2019 Vincent T Mensen, Annabel Vreeker, Johan Nordgren et al.

Background: Synthetic cannabinoids (SCs) are a class of new psychoactive substances that have been rapidly evolving around the world throughout recent years. Many different synthetic cannabinoid analogues are on the consumer market and sold under misleading names, like "spice" or "incense." A limited number of studies have reported serious health effects associated with SC use. In this study,...

DOI: 10.1007/s00213-019-05238-8 (opens in new tab) Full text (opens in new tab) Humans Marijuana abuse Cannabinoids Marijuana smoking +16

Daily, high‐potency cannabis linked to first psychosis

Alcoholism & Drug Abuse Weekly April 8, 2019 Alison Knopf

Daily use of marijuana (cannabis) is associated with a greater than three times increased risk of psychotic disorder compared to never users, according to a study published in Lancet Psychiatry. This risk increased to nearly five times if high‐potency cannabis was used. Across the 11 sites included in the study, if high‐potency cannabis were not available, 12.2 percent of cases of first‐episode...

Adolescent exposure to Δ9-tetrahydrocannabinol alters the transcriptional trajectory and dendritic architecture of prefrontal pyramidal neurons.

Molecular Psychiatry April 2019 Michael L Miller, Benjamin J. Chadwick, Dara L Dickstein et al.

Neuronal circuits within the prefrontal cortex (PFC) mediate higher cognitive functions and emotional regulation that are disrupted in psychiatric disorders. The PFC undergoes significant maturation during adolescence, a period when cannabis use in humans has been linked to subsequent vulnerability to psychiatric disorders such as addiction and schizophrenia. Here, we investigated in a rat...

Cannabis y el cerebro adolescente

Revista médica de Chile April 1, 2019 Manuel E. Cortés, Yanara A Bernal, Renán Orellana 4 citations

Señor Editor:La legalización del uso medicinal y recreativo de la marihuana (Cannabis sativa) es un tema de controversia mundial.Un artículo en Nature Reviews Neuroscience 1 destaca que el uso de Cannabis es cada vez más importante para la medicina moderna, especialmente en el tratamiento del dolor y de trastornos motores.Sin embargo, su uso más extendido es «recreacional» debido a las...

Cannabis (Marijuana)

MOJ Addiction Medicine & Therapy March 21, 2019 N. Vallejo

Cannabis Sativa is the most consumed drug in the world next to alcohol. This article describes its effects, especially that of D9-THC. The perception of the risk of smoking Cannabis has followed a downward curve in the last 15years Granting it to connotation of "recreational" and ignoring or ignoring its risks for psychophysical health. In some countries of the Northern Hemisphere it is usually...